Argon-based inhalable gaseous medicinal product for the treatment of neurointoxications
    18.
    发明申请
    Argon-based inhalable gaseous medicinal product for the treatment of neurointoxications 审中-公开
    氩气可吸入气体药物治疗神经毒素

    公开(公告)号:US20070275089A1

    公开(公告)日:2007-11-29

    申请号:US11836536

    申请日:2007-08-09

    CPC classification number: A61K33/00

    Abstract: The invention relates to the use of argon gas for producing all or part of an inhalable medicinal product intended to prevent or treat a neurointoxication in humans. The medicinal product contains argon in an effective proportion and acts on at least one brain receptor in order to regulate the functioning of dopamine-, glutamate-, serotonin-, acetylcholine-, taurine-, GABA- and/or noradrenalin-mediated neurotransmission systems. Preferably, the proportion by volume of argon in the gaseous medicinal product is between 15 and 80%. The neurointoxication is chosen from excitotoxicities engendering a state of addiction, acute cerebral accidents, neurodegenerative diseases, and psychiatric or neurological pathologies, in particular anxiety conditions, psychotic conditions, in particular schizophrenia, and epilepsy in its various forms.

    Abstract translation: 本发明涉及使用氩气来生产旨在预防或治疗人类神经毒素的全部或部分可吸入药物。 药用产品含有有效比例的氩气,并且作用于至少一种脑受体,以调节多巴胺,谷氨酸,5-羟色胺,乙酰胆碱,牛磺酸,GABA和/或去甲肾上腺素介导的神经传递系统的功能。 优选地,气态医药产品中的氩气体积比例为15-80%。 神经排毒选自产生成瘾状态,急性脑意外,神经变性疾病,精神病学或神经病理学,特别是焦虑症,精神病状况,特别是精神分裂症和各种形式的癫痫的兴奋性毒性。

Patent Agency Ranking